Guadalupe García-Tsao, MD Professor of Medicine Yale University. Chief, Digestive Diseases Section VA-CT Healthcare System.
|
|
- Cornelius McGee
- 7 years ago
- Views:
Transcription
1 1 Management of Guadalupe García-Tsao, MD Professor of Medicine Yale University Chief, Digestive Diseases Section VA-CT Healthcare System I have no disclosures to make relative to my presentation. CIRRHOSIS IS THE MOST COMMON CAUSE OF ASCITES Cirrhosis is the Most Common Cause of Peritoneal malignancy Cirrhosis Heart failure Peritoneal tuberculosis Others Pancreatic Budd-Chiari syndrome Nephrogenic ascites Source of the main 3 causes of ascites Entity Source Pathophysiology Cirrhosis Hepatic sinusoid Fibrosis Patients and with nodules cirrhotic ascites causing have sinusoidal an HVPG and of at post-sinusoidal least 12 mmhg (nl 3-5) obstruction Morali et a. J Hepatol 22 Heart failure Hepatic sinusoid Congestion of liver due to right heart failure (posthepatic block) Peritoneal malignancy/tb Peritoneum Inflammation or infiltration of the peritoneum
2 2 Rationale Behind the Serum- Albumin Gradient (SAAG) (out of the sinusoid) (into the sinusoid) SIN hyd + PER onc = SIN onc + PER hyd SIN hyd = SIN onc - PER onc HVPG = Serum albumin - = SAAG albumin The Serum- Albumin Gradient (SAAG) Correlates With Sinusoidal Pressure 3 2 HVPG (mmhg) 11 1 r = SAAG (g/dl) 1.1 Hoefs J, J Lab Clin Med 1983; 12:26 Serum- Albumin Gradient and Protein Levels in the Most Common Causes of Serum ascites 2. albumin gradient (g/dl) 1. SERUM-ASCITES ALBUMIN GRADIENT (SAAG) AND ASCITES PROTEIN LEVELS IN THE MOST COMMON CAUSES OF ASCITES SAAG is an indicator of sinusoidal pressure. If >1.1 ascites is coming from the sinusoid Cirrhotic ascites Cardiac ascites Peritoneal malignancy
3 3 THE PERMEABILITY OF THE HEPATIC SINUSOID VARIES IN HEALTH AND DISEASE The Permeability of the Hepatic Sinusoid Varies in Health and Disease no basement membrane Hepatocytes The normal sinusoid is leaky Sinusoid fibrous tissue deposition capillarization of sinusoid In cirrhosis, the hepatic sinusoid is less leaky Sinusoid Serum- Albumin Gradient and Protein Levels in the Most Common Causes of Serum ascites 2. albumin gradient (g/dl) 1. SERUM-ASCITES ALBUMIN GRADIENT (SAAG) AND ASCITES PROTEIN LEVELS IN THE MOST COMMON CAUSES OF ASCITES SAAG is an indicator of sinusoidal pressure. If >1.1 ascites is coming from the sinusoid 1.1 Ascitic fluid total protein (g/dl) Cirrhotic ascites Runyon, Ann Intern Med 1992; 117:215 Cardiac ascites Peritoneal malignancy (75) 2.5 protein is an indicator of leakiness of sinusoid, >2.5 the sinusoid is leaky (i.e. normal) SAAG and ascites total protein can establish the differential among the main causes of ascites CONDITION Cirrhosis Peritoneal malignancy Heart failure SAAG high low high ASCITES PROTEIN low high high Cutoff 1.1 g/dl 2.5 g/dl
4 4 Serum BNP has a higher diagnostic accuracy for cardiac ascites than SAAG/ascites protein Rules in Rules out Test LR (+) (rules in) SAAG >1.1; prot > LR(-) (rules out) Serum BNP >364 pg/ml SAAG <1.1; prot < Serum BNP < 182 pg/ml. Patients with new onset ascites Farias et al. Hepatology 214; 59: Natural History of Chronic Liver Disease Chronic liver disease Compensated cirrhosis Decompensated cirrhosis VH Encephalopathy Death VH= variceal hemorrhage In a cohort of patients with compensated cirrhosis, ascites was the most common decompensating event Decompensation.5.25 VH HE Jaundice months D Amico G. Gastroenterology 21; 12: A2
5 5 Cirrhosis Intrahepatic resistance Portal (sinusoidal) hypertension Splanchnic / systemic vasodilatation Effective arterial blood volume Diuretics Sodium retention Activation of neurohumoral systems SPIRONOLACTONE IS MORE EFFECTIVE THAN FUROSEMIDE IN CIRRHOTIC PATIENTS WITH ASCITES Spironolactone is More Effective Than Furosemide in Uncomplicated Response No response Total Spironolactone (15-3 mg/d) Furosemide (8-16 mg/d) Perez-Ayuso et al. Gastroenterology 1983; 84:961 Treatment of ascites Not an emergency, treat ascites in a stepwise unhurried manner Other complications (GI bleed AKI, infection) are absent or have resolved If patient uncomfortable large volume paracentesis Treatment aimed at achieving a negative sodium balance
6 6 Less frequent dose reductions are needed when spironolactone is started alone Spironolactone alone* (n=5) Spironolactone + Furosemide (n=5) Response Rate 94% 98% Time to Response 12.8 days 12.3 days Dose reduction needed 34% p=.2 68% Santos et al., J Hepatol 23; 39:187 * Followed by furosemide if necessary In addition to spironolactone-based diuretics. Salt restriction (2g/day = ~9mEq/day) Do not compromise nutritional status Avoid non-steroidal anti-inflammatory drugs No water restriction unless serum Na <13 meq/l Low threshold to perform a diagnostic paracentesis to investigate SBP Management of Follow weight and labs (BUN, creatinine, lytes) Weight loss goals 2-3 lb a week; no more than 1 lb / day If no weight loss Make sure patient is not on NSAIDs Check urine Na. If any of the following, patient is eating too much salt: > 5 meq/l or greater than daily Na intake Spot UNa >UK (correlates with a 24-hour sodium excretion >78 meq/l)
7 7 Hepatic Hydrothorax Occurs in ~6% of patients with cirrhosis Krok KL, Cardenas A. Semin Respir Crit Care Med 212; 33: 3-1. Due to transdiaphragmatic movement of fluid from the peritoneum to the pleural space through diaphragmatic defects Management same as for cirrhotic ascites Cirrhosis Intrahepatic resistance Portal (sinusoidal) hypertension Splanchnic / systemic vasodilatation Effective arterial blood volume Activation of neurohumoral systems Sodium retention Refractory Large volume-paracentesis (LVP): Local therapy Recurrence of ascites is the rule May be associated with postparacentesis circulatory dysfunction
8 8 LVP WITHOUT ALBUMIN LEADS TO INCREASES INCIDENCE OF POST-PARACENTESIS CIRCULATORY DYSFUNCTION (PCD) LVP Without Albumin Leads to Increases in Renin, Renal Failure and Hyponatremia Plasma renin activity (ng/ml/h) ns p<.1 Postparacentesis circulatory dysfunction (PCD) % Renal failure / Hyponatremia p<.1 Before After Albumin Before After No albumin Albumin No albumin Gines et al., Gastroenterology 1988; 94:1493 CONSEQUENCES OF POST-PARACENTESIS CIRCULATORY DYSFUNCTION (PCD) Consequences of post-paracentesis circulatory dysfunction (PCD) Shorter time to ascites recurrence Higher incidence of hyponatremia and renal dysfunction Higher mortality Gines et al., Gastroenterology 1996; 111:12; Ruiz del Arbol et al., Gastroenterology 1997; 113:579 Post-paracentesis circulatory dysfunction (PCD) is lowest in patients receiving albumin after LVP % Development of PCD No expander Saline Synthetic expander Albumin* 1 Overall Gines et al., Gastroenterology 1988; 94:1493; Gines et al., Gastroenterology 1996; 111:12; Sola-Vera et al., Hepatology 23; 37:1147 <5-6 L >5-6 L removed *6-8 g per liter of ascites removed
9 9 Cirrhosis Intrahepatic resistance Portal (sinusoidal) hypertension Other volume expanders? Vasoconstrictors? LVP Splanchnic / systemic vasodilatation Effective arterial blood volume ALBUMIN Activation of neurohumoral systems Sodium retention Water retention Renal vasoconstriction Refractory Hyponatremia Hepatorenal syndrome Compared to alternative treatment, albumin reduces the rate of PCD Favors albumin Favors control Bernardi et al. Hepatology 212;55:1172. Recurrence of ascites is no different in patients treated with LVP + albumin vs. octreotide/midodrine PCD : 18% (2/11) with Albumin 25% (2/8) with Octreotide/Midodrine (p=.574) Bari et al. Accepted Clin Gastroenterol Hepatol.
10 1 THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT Transjugular Intrahepatic Portosystemic Shunt Hepatic vein TIPS Portal vein Splenic vein Superior mesenteric vein In Lebrec refractory (1996) 2 ascites, TIPS is more effective than LVP in preventing ascites recurrence Recurrence of ascites.14 (.8-.26) Encephalopathy Death Death (excluding Lebrec) 2.34 ( ).9 ( ) Heterogeneity 2 p=.5.74 ( ) Better TIPS Better LVP Odds ratio D Amico et al. Gastroenterology 25; 129:1282 In a meta-analysis of individual patient data, survival was better with TIPS than LVP Survival Encephalopathy p=.36 P=.5 Greater survival benefit in patients treated with TIPS who had a MELD score <15 TIPS= transjugular intrahepatic portosystemic shunt LVP= large-volume paracentesis *individual data meta-analysis Salerno et al. Gastroenterology 27;133:
11 11 Refractory hepatic hydrothorax A trial of in-hospital diuretic therapy should be attempted Serial thoracenteses may be required too frequently Chest tube or indwelling catheter should not be placed ( infection, AKI) TIPS may need to be considered earlier Clinical response (67%) and survival are also associated with pre-tips MELD <15 Dhanasekaran et al. Am J GE 21. Peritoneo-Venous Shunt (PVS) is Useful in the Treatment of Refractory Use of jugular vein will hinder TIPS placement Indicated in malignant ascites or patients who are not transplant or TIPS candidates One-way valve Intraabdominal adhesions may complicate liver transplant surgery Pilot safety study of Automated Low-Flow pump for refractory (ALFA) (n=4) ALFA pump transfers ascites into the bladder Placed under general anesthesia 6-month followup LVP per month Infections antibiotic prophylaxis (76% 42%) Catheter dislodgement/problems (1/4=25%) Surgical complications (5/4) Progressive decrease in serum albumin 13 early termination, 8 died, 2 txp Bellot et al. J Hepatol 213;58:922-7
12 12 In patients with large varices that have not bled, a decrease in HVPG >1% leads to less ascites, RA and HRS Refractory ascites Hepatorenal syndrome Hernandez-Gea et al. Am J Gastroenterol 212; 17: Cirrhotic ascites The most common decompensating event in cirrhosis It is not an emergency unless complicated by infection or hepatorenal syndrome Ideal treatment strategies should be based on its pathophysiology Increase sodium excretion Decrease sinusoidal pressure Remove fluid while replenishing intravascular volume
Evaluation and Prognosis of Patients with Cirrhosis
Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded
More informationEnd Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012
End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 Natural History of ESLD Increasing liver fibrosis Development of HCC Chronic liver disease Compensated cirrhosis Decompensated cirrhosis
More informationMANAGEMENT OF LIVER CIRRHOSIS
MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different
More informationJune 11, 2015 Tim Halterman
June 11, 2015 Tim Halterman Defini&on Histologic change + loss of liver function Derives from Greek word kirrhos meaning yellow, tawny First named by Rene Laennec in 1819 Laennec s cirrhosis=alcoholic
More informationCOMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D.
1 COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST COMPLICATIONS OF CIRRHOSIS Philip C. Delich, M.D. Faculty Disclosure Dr. Delich has indicated that he does not have any relevant financial
More informationCOMPLICATIONS OF CIRRHOSIS: CASES. Anil Seetharam, MD Anil.Seetharam@bannerhealth.com
COMPLICATIONS OF CIRRHOSIS: CASES Anil Seetharam, MD Anil.Seetharam@bannerhealth.com Defining Cirrhosis Histological diagnosis Nodules of regenerating hepatocytes surrounded by fibrous tissue Common final
More informationAfter the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH
After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco
More informationPerspective End-Stage Liver Disease in HIV Disease
Perspective End-Stage Liver Disease in HIV Disease Liver disease is the most common non AIDS-related cause of mortality in HIV-infected patients. HIV-infected patients with chronic liver disease progress
More informationCASE REPORT. T. L. Krishnamoorthy 1, M. Taneja 2 & P. E. Chang 1. Key Clinical Message
CASE REPORT Symptomatic hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt (TIPS) role of titration of portosystemic gradient reduction to avoid post- TIPS encephalopathy
More informationComplications of Cirrhosis
Complications of Cirrhosis What is Cirrhosis? Paul J. Gaglio, MD Center for Liver Disease and Transplantation Columbia University College of Physicians and Surgeons NAFLD 1 Decreased clearance of Estrogen
More informationCirrhosis and HCV. Jonathan Israel M.D.
Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment
More informationa series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION
www.hcvadvocate.org HCSP FACT SHEET Symptoms & Complications of Cirrhosis Foreword After many years of infection with hepatitis C the liver can become severely scarred. The process starts with inflammation
More informationPathophysiology of Portal Hypertension
Pathophysiology of Portal Hypertension Jaime Bosch, M.D. Professor of Medicine, University of Barcelona Liver Unit, Hospital Clínic-IDIBAPS, Centro de Investigación Biomédica de Enfermedades Hepáticas
More informationScreening for Varices and Prevention of Bleeding
Hepatitis C Online PDF created August 24, 2016, 3:30 am Screening for Varices and Prevention of Bleeding Module 3: Lesson 3: Contents: Management of Cirrhosis-Related Complications Screening for Varices
More informationAcute on Chronic Liver Failure: Current Concepts. Disclosures
Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures
More informationCARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS
LUCIAN BLAGA UNIVERSITY OF SIBIU VICTOR PAPILIAN FACULTY OF MEDICINE CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS Ph.D. THESIS SUMMARY COORDINATOR: PROF.DR. MANIŢIU IOAN Ph.D. STUDENT: LORENA MĂRIEŞ SIBIU
More informationNUTRITION IN LIVER DISEASES
NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV
More informationComplications of Chronic Liver Disease
Complications of Chronic Liver Disease By Rima A. Mohammad, Pharm.D., BCPS Reviewed by Paulina Deming, Pharm.D.; Marisel Segarra-Newnham, Pharm.D., MPH, FCCP, BCPS; and Kelly S. Bobo, Pharm.D., BCPS Learning
More informationA 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation.
A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation. Three years ago he was treated with 24 weeks of peginterferon alfa-2a (180 µg/wk, PEGIFN)
More informationStudy of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis
Research Article Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis RR. Pawar*, ML. Pardeshi and BB. Ghongane Department of Pharmacology, B.J. Medical
More informationHepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs
Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi
More informationThe State of the Liver in the Adult Patient after Fontan Palliation
The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital
More informationTransplantUpdate. A Report From Baylor Regional Transplant Institute Volume 2 Number 1
TransplantUpdate A Report From Baylor Regional Transplant Institute Volume 2 Number 1 Treatment of Ascites 2 Ascites the accumulation of fluid in the abdominal cavity is the most common complication of
More informationPRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT
PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON
More informationLIVER TRANSPLANTATION IN ALAGILLE SYNDROME
LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic
More informationApproach to Abnormal Liver Tests
Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School
More informationPEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationProgram Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.
1 Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the
More informationSignificance of Serum Ascites Albumin Gradient and Ascitic Fluid Cholesterol in Classification of Ascites
ORIGINAL ARTICLE Significance of Serum Ascites Albumin Gradient and Ascitic Fluid Cholesterol in Classification of Ascites 1 B.Venugopal, 2 B.Sai Ravi Kiran, 3 G.Surya Prakash 4 E.Prabhakar Reddy ABSTRACT
More informationManagement of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok
Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US
More informationLiver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels
Liver Failure Nora Aziz www.3bv.org Bones, Brains & Blood Vessels Severe deterioration in liver function Looses ability to regenerate/repair decompensated Liver extensively damaged before it fails Equal
More informationPatterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function
More informationPerspective Advanced Liver Disease: What Every Hepatitis C Virus Treater Should Know
Perspective Advanced Liver Disease: What Every Hepatitis C Virus Treater Should Know Identification and treatment of advanced hepatitis C virus (HCV) infection is often challenging. Accurate fibrosis staging
More informationNew Anticoagulants and GI bleeding
New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit
More informationLiver Diseases. An Essential Guide for Nurses and Health Care Professionals
Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing
More informationPERITONEAL (ABDOMINAL) PARACENTESIS
PERITONEAL (ABDOMINAL) PARACENTESIS Indications 1. To determine the cause of ascites. 2. To determine if ascites is infected. 3. For therapeutic removal of fluid: (a) (b) When distention is pronounced
More informationHYPERTENSION ASSOCIATED WITH RENAL DISEASES
RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein
More information1802 CLINICAL REVIEWS
1802 CLINICAL S nature publishing group Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center
More informationDiseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32
Diseases of peritoneum Lect Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32 Describe the etiology, pathogenesis and types of peritonitis Define ascites and
More informationThe use of TIPS in chronic liver disease
Annals of Hepatology 2006; 5(1): January-March: 5-15 Concise Review Annals of Hepatology The use of TIPS in chronic liver disease Florence Wong 1 Abstract The development of cirrhosis and portal hypertension
More informationCirrhosis and Ascites. Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961
Cirrhosis and Ascites Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961 Overview Liver weighs about 3 pounds and is the largest organ in the body. It is located in the upper right side of the
More informationTherapy of decompensated cirrhosis Pre-transplant for HBV and HCV
Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Universitätsklinikum Leipzig Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Leber- und Studienzentrum
More informationThe Management of Ascites and Hyponatremia in Cirrhosis
The Management of Ascites and Hyponatremia in Cirrhosis Pere Ginès, M.D., 1 and Andrés Cárdenas, M.D., M.M.Sc. 2 ABSTRACT Ascites is the most common complication of cirrhosis and is associated with an
More informationManagement of Adult Patients with Ascites Due to Cirrhosis: Update 2012
PRACTICE Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 Bruce A. Runyon Jump to: Contents (click section title or page number) Recommendations and Rationales... 3 Full-text Guideline....56
More informationRenovascular Hypertension
Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension
More informationHemodynamic Disorders Edema, Hyperemia/Congestion, Hemorrhage
Michele D. Raible, M.D., Pharm.D. UIC College of Medicine Deputy Head for Pathology Education M2 Pathology Course Assistant Professor of Clinical Pathology,UIC Lecture #12 Phone: 312-996-7250 Monday, September
More informationAlcoholic Hepatitis (Teacher s Guide)
Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationLeading the Way to Treat Liver Cancer
Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale
More informationEconomic Impact of Treatment Options for Hepatic Encephalopathy
Economic Impact of Treatment Options for Hepatic Encephalopathy Carroll B. Leevy, M.D. 1 ABSTRACT Complications of chronic liver disease, such as hepatic encephalopathy (HE), can have a substantial impact
More informationAASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
AASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, 1 Arun J. Sanyal, 2 Norman D. Grace, 3 William Carey, 4 and the
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationThe Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting
More informationReview. Current management of the complications of portal hypertension: variceal bleeding and ascites. bleeding. 20
Current management of the complications of portal hypertension: variceal bleeding and ascites Nina Dib, Frédéric Oberti, Paul Calès DOI:10.1503/cmaj.051700 Abstract Portal hypertension is one of the main
More informationInpatient Heart Failure Management: Risks & Benefits
Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical
More informationLiver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
More informationRecanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension
Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension Audrey Galey RDMS, RVT, Mary Grace Renfro RDSM, RVT, Lindsey Simon, RVT March 22, 2013 2 Abstract A recanalized umbilical
More informationAscites refers to the pathologic accumulation of fluid within the peritoneal cavity. It is important
Approach to the Patient with Ascites Differential Diagnosis Ascites refers to the pathologic accumulation of fluid within the peritoneal cavity. It is important to establish a cause for its development
More informationDiabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
More informationSeptic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident
Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor
More informationClinical Aspects of Hyponatremia & Hypernatremia
Clinical Aspects of Hyponatremia & Hypernatremia Case Presentation: History 62 y/o male is admitted to the hospital with a 3 month history of excessive urination (polyuria) and excess water intake up to
More informationLiver, Gallbladder, Exocrine Pancreas KNH 406
Liver, Gallbladder, Exocrine Pancreas KNH 406 2007 Thomson - Wadsworth LIVER Anatomy - functions With disease blood flow becomes obstructed Bile All bile drains into common hepatic duct Liver Bile complex
More informationFREQUENCY OF PERITONEAL INFECTIONS AMONG PATIENTS UNDERGOING CONTINUOUS PARACENTESIS WITH AN INDWELLING CATHETER
FREQUENCY OF PERITONEAL INFECTIONS AMONG PATIENTS UNDERGOING CONTINUOUS PARACENTESIS WITH AN INDWELLING CATHETER Abdul Nadir, David H Van Thiel* Maricopa Medical Centre, Phoenix AZ, *Division of Gastroenterology,
More informationTHE YELLOW PATIENT : Acutely Presenting Decompensated Chronic Liver Disease. Dr Shahid A Khan. Case. Q for Discussion:
THE YELLOW PATIENT : Acutely Presenting Decompensated Chronic Liver Disease Topics we ll cover Alcoholic Hepatitis Ascites and Spontaneous Bacterial Peritonitis Hepatorenal Syndrome Hepatic Encephalopathy
More informationLiver Function Essay
Liver Function Essay Name: Quindoline Ntui Date: April 20, 2009 Professor: Dr. Danil Hammoudi Class: Anatomy and Physiology 2 Liver function The human body consist of many highly organize part working
More informationOptimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado
Optimal Management of Splenic/Portal Vein Thrombosis David Mauchley University of Colorado Overview Portal Vein Thrombosis (PVT) Etiology Presentation/Clinical Aspects Diagnosis Management Cirrhotic vs.
More informationNurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP. Amanda Tinning MN NP October 13, 2011
Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP Amanda Tinning MN NP October 13, 2011 Overview Define clinical outcomes Discuss the contributions of the NP role
More informationHEPATOLOGY CLERKSHIP
College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,
More informationGASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo
GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo Educational Purpose: The Hepatology Rotation introduces the fellow to the management of outpatients and inpatients
More informationPHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
More informationFigure 1. Location of liver in the body. Figure 2. Clinical manifestations of portal hypertension
Portal Hypertension: Introduction As early as the 17th century, it was realized that structural changes in the portal circulation could cause gastrointestinal bleeding. In 1902, Gilbert and Carnot introduced
More informationInterpretation of Laboratory Values
Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances
More informationAssessing the risk of surgery in patients with liver disease
REVIEW CME CREDIT AMITABH SUMAN, MD VA Medical Center and Shands Hospital at University of Florida, Gainesville WILLIAM D. CAREY, MD Director, Center for Continuing Education; Department of Gastroenterology,
More informationREVIEW CLINICAL REVIEWS
1802 CLINICAL S nature publishing group Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center
More informationOMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!
How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy
More informationADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.
More informationDehydration & Overhydration. Waseem Jerjes
Dehydration & Overhydration Waseem Jerjes Dehydration 3 Major Types Isotonic - Fluid has the same osmolarity as plasma Hypotonic -Fluid has fewer solutes than plasma Hypertonic-Fluid has more solutes than
More informationA CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY
A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY 2 1 Mr N.N. 56 yr old male. Admitted on 22/03/02. 1 month Hx of abdominal distention, confusion, inability to concentrate and dyspnoea Grade 111. Pmx:
More informationUnderstanding Treatment Options for Renal Therapy
Understanding Treatment Options for Renal Therapy Kidney failure happens to many different people for many different reasons 1 What causes kidney failure? Diabetes Chronic infection High blood pressure
More informationAcid-Base Balance and the Anion Gap
Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very
More informationSaint Francis Kidney Transplant Program Issue Date: 6/9/15
Kidney Transplant Candidate Informed Consent Education Here are educational materials about Kidney Transplant. Please review and read these before your evaluation visit. The RN Transplant Coordinator will
More informationThe following should be current within the past 6 months:
EVALUATION Baseline Labs Obtain at time or prior to initial evaluation CBC with diff PT/INR CMP HCV Genotype (obtained PRIOR TO consult visit) HCV RNA (obtained PRIOR TO consult visit) Hep A IgG Hep BsAg,
More informationChronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
More informationLamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine
Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationThe development of acute kidney injury (AKI) in
Acute Kidney Injury in Cirrhosis Guadalupe Garcia-Tsao, 1 Chirag R. Parikh, 2 and Antonella Viola 1,3 Acute renal failure (ARF), recently renamed acute kidney injury (AKI), is a relatively frequent problem,
More informationType II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
More informationUltrafiltration in PD: Physiologic Principles
Ultrafiltration in PD: Physiologic Principles Ali K. Abu-Alfa, MD, FASN Professor of Medicine Head, Division of Nephrology and Hypertension American University of Beirut Beirut, Lebanon Adjunct Faculty
More informationCirrhosis: Diagnosis, Management, and Prevention
: Diagnosis, Management, and Prevention S. PAUL STARR, MD, and DANIEL RAINES, MD, Louisiana State University Health Sciences Center School of Medicine at New Orleans, New Orleans, Louisiana Cirrhosis is
More informationSepsis: Identification and Treatment
Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge
More informationCirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. the diagnosis and evaluation of cirrhosis
Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment JOEL J. HEIDELBAUGH, M.D., and MARYANN SHERBONDY, M.D. University of Michigan Medical School, Ann Arbor, Michigan Major complications
More informationThings You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
More informationDiagnostics: Page 2 of 5
Proteinuria Proteinuria is a condition in which there are increased amounts of protein in the urine. There are a number of different diseases which can result in proteinuria. In the early stages of the
More informationRATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
More informationLiving With Advanced Liver Disease
2014 Living With Advanced Liver Disease This book belongs to: repared by: Multi Organ Transplant rogram QEII Health Sciences Centre Halifax, NS Tel 902-473-1256 Fax 902-473-5898 Website: www.mydoctor.ca
More informationKidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE
Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.
More informationS0140-6736(14)60121-5
Liver cirrhosis Emmanuel A Tsochatzis, Jaime Bosch, Andrew K Burroughs Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being the 14th most common cause of death
More informationchronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
More information